ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $381,835 | -18.3% | 17,735 | +2.3% | 0.00% | 0.0% |
Q1 2024 | $467,247 | -17.4% | 17,344 | -8.1% | 0.00% | -25.0% |
Q4 2023 | $565,354 | +72.1% | 18,864 | +17.6% | 0.00% | +33.3% |
Q3 2023 | $328,578 | +6.0% | 16,036 | +2.8% | 0.00% | 0.0% |
Q2 2023 | $309,992 | +5.8% | 15,601 | -8.8% | 0.00% | 0.0% |
Q1 2023 | $293,077 | -2.9% | 17,109 | +11.0% | 0.00% | 0.0% |
Q4 2022 | $301,691 | +62.2% | 15,416 | +32.6% | 0.00% | +50.0% |
Q3 2022 | $186,000 | +19.2% | 11,629 | +2.4% | 0.00% | 0.0% |
Q2 2022 | $156,000 | -6.0% | 11,352 | +8.6% | 0.00% | +100.0% |
Q1 2022 | $166,000 | -25.9% | 10,452 | +1.7% | 0.00% | -50.0% |
Q4 2021 | $224,000 | -27.7% | 10,273 | -0.8% | 0.00% | -33.3% |
Q3 2021 | $310,000 | -29.1% | 10,361 | +4.9% | 0.00% | -25.0% |
Q2 2021 | $437,000 | +11.5% | 9,874 | +11.7% | 0.00% | +33.3% |
Q1 2021 | $392,000 | -18.8% | 8,843 | +0.4% | 0.00% | -25.0% |
Q4 2020 | $483,000 | +131.1% | 8,808 | -3.8% | 0.00% | +100.0% |
Q3 2020 | $209,000 | – | 9,154 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |